Belx Bio-Pharmaceutical Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Belx Bio-Pharmaceutical General Information

Description

Developer of botanical drugs intended for the treatment of tumors and chronic liver diseases. The company's drugs have improved therapeutic outcomes and fewer side effects can be used simultaneously in combination with existing cancer drugs, it manufactures botanical drugs on par with pharmaceutical companies and follows a thorough six-step process, which also includes clinical trials and producing plant-based pharmaceutical interventions, enabling medical practitioners to improve treatment efficacy and the quality of life for cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rm. 536, Bldg. 52, 195, Sec. 4, Chung Hsing Rd., Chutung, Hsinchu
  • 31040, Taiwan, ROC
  • Hsinchu County
  • Taiwan
+886 03
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Rm. 536, Bldg. 52, 195, Sec. 4, Chung Hsing Rd., Chutung, Hsinchu
  • 31040, Taiwan, ROC
  • Hsinchu County
  • Taiwan
+886 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Belx Bio-Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC Completed Clinical Trials - Phase 1
4. Later Stage VC Completed Clinical Trials - Phase 1
3. Grant 01-Nov-2019 Completed Clinical Trials - Phase 1
2. Grant 01-Sep-2018 Completed Clinical Trials - Phase 1
1. Grant 01-Jan-2018 Completed Clinical Trials - Phase 1
To view Belx Bio-Pharmaceutical’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Belx Bio-Pharmaceutical Patents

Belx Bio-Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022205137-A1 Polymeric proanthocyanidin composition and application thereof Inactive 31-Mar-2021
AU-2022202161-A1 Polymeric proathocyanidin composition and application thereof Active 31-Mar-2021
AU-2022202161-B2 Polymeric proathocyanidin composition and application thereof Inactive 31-Mar-2021
CA-3153407-A1 Polymeric proathocyanidin composition and application thereof Active 31-Mar-2021
EP-4066828-A1 Polymeric proathocyanidin composition and application thereof Inactive 31-Mar-2021 A61K31/765
To view Belx Bio-Pharmaceutical’s complete patent history, request access »

Belx Bio-Pharmaceutical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
ITO Invest Taipei Government Minority
Ministry of Economic Affairs Government Minority
Innovation Industrial Technology Transfer Corporate Venture Capital Minority
Silicon Valley Advantage Accelerator/Incubator
To view Belx Bio-Pharmaceutical’s complete investors history, request access »

Belx Bio-Pharmaceutical FAQs

  • When was Belx Bio-Pharmaceutical founded?

    Belx Bio-Pharmaceutical was founded in 2016.

  • Where is Belx Bio-Pharmaceutical headquartered?

    Belx Bio-Pharmaceutical is headquartered in Hsinchu County, Taiwan.

  • What industry is Belx Bio-Pharmaceutical in?

    Belx Bio-Pharmaceutical’s primary industry is Drug Discovery.

  • Is Belx Bio-Pharmaceutical a private or public company?

    Belx Bio-Pharmaceutical is a Private company.

  • What is Belx Bio-Pharmaceutical’s current revenue?

    The current revenue for Belx Bio-Pharmaceutical is .

  • Who are Belx Bio-Pharmaceutical’s investors?

    ITO Invest Taipei, Ministry of Economic Affairs, Innovation Industrial Technology Transfer, and Silicon Valley Advantage have invested in Belx Bio-Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process